Open AccessEffect of anti-VEGF treatment on retinopathy of prematurity in Zone II Stage 3+
Author(s) -
Xiumei Yang,
Yue-Xiang Zhao,
Zonghua Wang,
Lu Liu
Publication year - 2018
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2018.04.17
Subject(s) - medicine , retinopathy of prematurity , ranibizumab , birth weight , gestational age , ophthalmology , fundus (uterus) , stage (stratigraphy) , surgery , pregnancy , bevacizumab , chemotherapy , paleontology , genetics , biology
To evaluate the effect of intravitreal ranibizumab injection for retinopathy of prematurity (ROP) in Zone II Stage 3 + .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom